CD8A and neoplasm: Immunofluorescence staining was used to assess the proliferation of CD4+ HTLs and CD8+ CTLs in order to further illustrate the anti-tumor immune response of the self-driven probiotic CRISPR/Cas9 delivery nanosystem strategy.